Disorder of endocrine ovary
|
0.010 |
Biomarker
|
group |
BEFREE |
These findings collectively identify that MRPS22, a component of the small mitochondrial ribosome subunit, is critical for ovarian development and may therefore provide insight into the pathophysiology and treatment of ovarian dysfunction.
|
29566152 |
2018 |
Acidosis, Lactic
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Here, we present a neonate with fatal lactic acidosis and combined OXPHOS deficiency caused by a homozygous mutation in MRPS22, a gene encoding a mitochondrial ribosomal small subunit protein.
|
25663021 |
2015 |
Congenital Heart Defects
|
0.010 |
GeneticVariation
|
group |
BEFREE |
MRPS22 mutation causes fatal neonatal lactic acidosis with brain and heart abnormalities.
|
25663021 |
2015 |
Hypertrophic obstructive cardiomyopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy.
|
21189481 |
2011 |
Ovarian Failure, Premature
|
0.020 |
Biomarker
|
disease |
BEFREE |
This analysis identified likely damaging, potentially contributing variants and molecular diagnoses in 16 families (44%), including 11 families with likely damaging variants in known genes and five families with predicted deleterious variants in disease genes (IGSF10, MND1, MRPS22, and SOHLH1) not previously associated with POI.
|
31042289 |
2019 |
Ovarian Failure, Premature
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In contrast to prior reports of mutations in MRPS22 associated with severe mitochondrial disease, the POI phenotype is far less severe.
|
29566152 |
2018 |
Mitochondrial Diseases
|
0.030 |
GeneticVariation
|
group |
BEFREE |
In contrast to prior reports of mutations in MRPS22 associated with severe mitochondrial disease, the POI phenotype is far less severe.
|
29566152 |
2018 |
Mitochondrial Diseases
|
0.030 |
GeneticVariation
|
group |
BEFREE |
A patient with mitochondrial disorder due to a novel mutation in MRPS22.
|
28752220 |
2017 |
Mitochondrial Diseases
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation.
|
17873122 |
2007 |
Birth Weight
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
|
31043758 |
2019 |
46, XX Gonadal Sex Reversal
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Mutations in the mitochondrial ribosomal protein MRPS22 lead to primary ovarian insufficiency.
|
29566152 |
2018 |
Alopecia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic prediction of male pattern baldness.
|
28196072 |
2017 |
Movement Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
A patient with mitochondrial disorder due to a novel mutation in MRPS22.
|
28752220 |
2017 |
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
A patient with mitochondrial disorder due to a novel mutation in MRPS22.
|
28752220 |
2017 |
Other alopecia
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Androgenetic Alopecia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Ovarian Mucinous Adenocarcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
Alopecia, Androgenetic, 3
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Androgenetic, 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Androgenetic, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Male Pattern
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Movement Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Whole exome sequencing in patients with white matter abnormalities.
|
27159321 |
2016 |
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Whole exome sequencing in patients with white matter abnormalities.
|
27159321 |
2016 |
Other alopecia
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Androgenetic Alopecia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |